Maximiscin Induces DNA Damage, Activates DNA Damage Response Pathways, and Has Selective Cytotoxic Activity against a Subtype of Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

Maximiscin Induces DNA Damage, Activates DNA Damage Response Pathways, and Has Selective Cytotoxic Activity against a Subtype of Triple-Negative Breast Cancer

Published:2016-06-16 Issue:7 Volume:79 Page:1822-1827
ISSN:0163-3864
Container-title:Journal of Natural Products
language:en
Short-container-title:J. Nat. Prod.

Author:

Robles Andrew J.¹²,Du Lin¹²,Cichewicz Robert H.¹²,Mooberry Susan L.¹²

Affiliation:

1. Department of Pharmacology and ‡Cancer Therapy & Research Center, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900, United States

2. Natural Product Discovery Group, Institute for Natural Products Applications and Research Technologies, and ⊥Department of Chemistry & Biochemistry, Stephenson Life Science Research Center, University of Oklahoma, 101 Stephenson Parkway, Norman, Oklahoma 73019-0390, United States

Funder

National Cancer Institute

University of Texas Health Science Center at San Antonio

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jnatprod.6b00290

Reference22 articles.

1. Outcomes by Tumor Subtype and Treatment Pattern in Women With Small, Node-Negative Breast Cancer: A Multi-Institutional Study